IL-15 or its agonists have not been shown to play a direct role in regulating MDSC expansion or activity, thus it is anticipated that ALT-803 therapy may only have marginal effect in the population of MDSCs in tumor infiltrates. This evidence concerns the gene IL15 and neoplasm.